Patti Oto, R.Ph. joined Astex Pharmaceuticals, Inc. in January 2020 as Global Vice President of Regulatory Affairs with over 35 years experience in the Pharmaceutical and Medical Device Industry. Prior to Astex, Patti was at Chrono Therapeutics in the role of Senior Vice President of Regulatory and Quality where she managed the regulatory, clinical and quality activities for a drug device combination including a digital health program. Previous to Chrono, Patti worked in roles of increasing responsibilities in quality, clinical and regulatory at The Medicines Company (previously Incline Therapeutics) Onyx Pharmaceuticals (Amgen), Corgentech (Anesiva), Coulter (Corixa, GlaxoSmithKline), Genentech (Roche), and Syntex. Patti has worked on global regulatory submissions in support of marketing authorizations for biologics, drugs and drug/device combination products in several therapeutic areas including cardiovascular, metabolics, pulmonary, oncology, addiction and pain management. Patti is a registered pharmacist and received her B.S. in Pharmacy from the University of New Mexico.